Neurotech Daily 8. The Future of Neuro-Rehabilitation and BCI with g.tec | Christoph Guger
12 snips
Sep 24, 2023 Christoph Guger, founder and CEO of g.tec and long-time BCI researcher and entrepreneur. He discusses Recoverix and EEG-driven motor-imagery rehab. He explains pairing BCI detection with electrical stimulation, clinical evidence for stroke and MS improvements, personalized calibration and performance biomarkers, device challenges, and broader BCI applications and future directions.
AI Snips
Chapters
Transcript
Episode notes
Motor Training Yields Unexpected Cognitive And Speech Gains
- Recoverix activates mirror neuron systems via an avatar and targets the sensory-motor cortex, producing side benefits like reduced spasticity, less chronic limb pain, improved concentration, memory, and speech.
- Activating motor cortex indirectly benefits the broader speech network by improving motor control of lips and tongue.
Ship Clinical Evidence And A Standard Procedure
- Use completed clinical studies and a strict standard operating procedure to make neurorehabilitation scalable and predictable.
- g.tec's trials show significant improvements even decades after stroke, making standardized protocols crucial for reproducible outcomes.
Recalibrate BCIs Every Session For Personalized Control
- Recalibrate BCI each session and train on sensors covering both healthy and paretic motor regions so machine learning picks electrodes that maximize classification accuracy.
- Rapid recalibration captures session-to-session brain changes and supports neuroplastic gains across treatments.